000597 东北制药
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(73,963)1,106,382758,761586,7521,108,571
投资活动产生之现金流量净额(257,199)(89,367)(283,967)(227,965)(256,341)
筹资活动产生之现金流量净额253,944(238,950)(1,153,438)381,099(58,986)
汇率变动对现金及现金等价物的影响(27,151)(23,810)9,6796,2956,913
现金及现金等价物净增加/(减少)(104,369)754,256(668,964)746,180800,157
期初现金及现金等价物余额2,852,2472,097,9922,766,9562,020,7761,220,619
期末现金及现金等价物余额2,747,8782,852,2472,097,9922,766,9562,020,776